Anti-CD22 (pinatuzumab biosimilar) mAb

Name: Anti-CD22 (pinatuzumab biosimilar) mAb - 专注肿瘤免疫
SKU: BME100029
Price: 160.00 CNY
Availability: InStock

Price: 50 μg ￥800.00 ; 100 μg ￥1500.00

SKU: BME100029 Category: Biosimilar reference antibodies

Datasheet

MSDS

Product Data

Common Name	ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000
Synonyms	CD22;SIGLEC2;BL-CAM;SIGLEC-2;Siglec2;SIGLEC2FLJ22814
Applications	ELISA; Flow Cyt
Recommended Dilutions	ELISA 1:5000-10000; Flow Cyt 1:100
Formulation & Reconstitution	Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Host Species	Humanized
IgG type	IgG1
Reactivity	Human
Target	CD22
Uniprot ID	P20273
Description	Anti-CD22 (pinatuzumab biosimilar) mAb
Delivery	In Stock
Storage & Shipping	Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
Background	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Usage	Research use only
Conjugate	Unconjugated

图片

Elisa-BME100029 Anti CD22 pinatuzumab vedotin biosimilar mAb Elisa fig1

Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μL/well) Human CD22, hFc-His tagged protein (PME100005) can bind Anti-CD22 Neutralizing antibody in a linear range of 3.2-400 ng/ml. In order to specifically detect BME100029, mouse anti-human Fab-specific antibody was used as detection antibody.

FC_combine-BME100029 Anti CD22 pinatuzumab vedotin biosimilar mAb FLOW Fig2

Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human CD22 (A) were surface stained with Anti-CD22 mAb 1 μg/ml (pinatuzumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.

Anti-CD22 (pinatuzumab biosimilar) mAb

Product Data

图片

相关产品

Login